JNP

Juniper Pharmaceuticals

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Juniper Pharmaceuticals, Inc. market cap is $127.71M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Juniper Pharmaceuticals, Inc. 52 week high is $13.25 as of October 25, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Juniper Pharmaceuticals, Inc. 52 week low is $4.30 as of October 25, 2025.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Juniper Pharmaceuticals, Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Juniper Pharmaceuticals, Inc. P/B ratio is 2.6335.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Juniper Pharmaceuticals, Inc.'s EBITDA is 392.19.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Juniper Pharmaceuticals, Inc. 50-day moving average is $10.47.

Juniper Pharmaceuticals, Inc. has 155 employees.